Biopharma leads sustained economic growth driven by IP-intensive industries

While the biopharmaceutical industry is the global leader in generating innovative medicines and technologies, lesser known is the industry ’s central role in sustaining economic growth. A recent study from NDP Analytics finds that intellectual property (IP)-intensive manufacturing industries have an outsized positive impact on the economy and support 57.6 million American jobs. The study also finds that the biopharmaceutical industry leads as a critical sector, driving economic progress and supporting quality jobs.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Intellectual Property Manufacturing Source Type: news